IndiaCOVID-19Ministry of Health and Family WelfareHealth

India’s Cumulative COVID-19 Vaccination Coverage exceeds 162.92 Cr

More than 62 lakh Vaccine Doses administered in the last 24 hours

Recovery Rate currently stands at 93.15%

2,55,874 New Cases reported in the last 24 hours

India’s Active Caseload currently stands at 22,36,842

Weekly Positivity Rate is presently at 17.17%

With the administration of more than 62 lakh Doses (62,29,956) vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 162.92 Cr (1,62,92,09,308) as per provisional reports till 7 am today.

This has been achieved through 1,77,12,517 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,03,92,701
2nd Dose 98,26,681
Precaution Dose 28,42,155
FLWs 1st Dose 1,83,91,675
2nd Dose 1,71,52,993
Precaution Dose 28,26,940
Age Group 15-18 years 1st Dose 4,27,23,464
Age Group 18-44 years 1st Dose 53,55,80,374
2nd Dose 39,10,87,802
Age Group 45-59 years 1st Dose 19,93,26,389
2nd Dose 16,73,04,587
Over 60 years 1st Dose 12,42,30,375
2nd Dose 10,43,90,089
Precaution Dose 31,33,083
Precaution Dose 88,02,178
Total 1,62,92,09,308

 

2,67,753 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 3,70,71,898.

Consequently, India’s recovery rate stands at 93.15%.

2,55,874 new cases were reported in the last 24 hours.

 

India’s Active Caseload is presently at 22,36,842. Active cases constitute 5.62% of the country’s total Positive Cases.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 16,49,108 tests being conducted. India has so far conducted over 71.88 Cr (71,88,02,433) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate in the country currently stands at 17.17% and the Daily Positivity rate also reported to be 15.52%.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker